Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of pyrazoloacridine in treating women who have refractory metastatic breast cancer.

Key facts

Study ID

NCT00003041

Run by

Ohio State University Comprehensive Cancer Center

Starts

1997-07-01

Expected to finish

2002-01-01

Last updated by the study team

2013-01-31

Who can join

Age: 16 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Central Baptist Hospital — Lexington, Kentucky, United States
• Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States
• Grant/Riverside Methodist Hospitals — Columbus, Ohio, United States
• Mount Carmel — Columbus, Ohio, United States
• Cancer Centers of the Carolinas — Greenville, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.